Gene · 2633
Papers1,970
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,970
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tiny tools closing the gap: nanobodies in research and therapy. | Function (Oxf) | 2026 | 41627946 | PubTator, text mining | PubMed |
| Loss of Cathepsin K Impairs Collagen Biogenesis and Enhances Actin Polymerization in Trabecular Meshwork. | Invest Ophthalmol Vis Sci | 2026 | 41615370 | PubTator, text mining | PubMed |
| Meta-unstable mRNAs in activated CD8+ T cells are defined by interlinked AU-rich elements and m6A mRNA methylation. | Nat Commun | 2026 | 41571642 | PubTator, text mining | PubMed |
| Corrigendum to "GBP1-CDK9-STAT3 signaling axis promotes osteosarcoma PD-L1 expression and immune escape" [Neoplasia 69 (2025) 101232]. | Neoplasia | 2026 | 41570446 | PubTator, text mining | PubMed |
| Identifying Crucial Genes Associated with Pyroptosis in Lupus Nephritis. | Inflammation | 2026 | 41545631 | PubTator, text mining | PubMed |
| Decoding Triphenotypic Neutrophils in Cervical Cancer Evolution and Targeting SPP1+/GBP1+/ELOVL5+ Tumor-Associated Neutrophils to Sensitize Immunotherapy. | Adv Sci (Weinh) | 2026 | 41313078 | PubTator, text mining | PubMed |
| The diagnostic value of combined detection of GBP1, IFN-γ and IL-2 in differentiating NTM from TB infection. | Clin Chim Acta | 2026 | 40850648 | PubTator, text mining | PubMed |
| ESM-1 and GBP-1 are associated with endothelial dysfunction: emerging biomarkers or key players in the pathophysiology of preeclampsia? | J Physiol | 2026 | 40042932 | PubTator, text mining | PubMed |
| Evaluation of host-immune biomarker signatures as multiplex qPCR diagnostic assays: a pilot study toward meeting WHO target product profiles for TB diagnosis in India. | Front Tuberc | 2025 | 42638755 | PubTator, text mining | PubMed |
| Overview of multi-omics approaches for pulmonary sarcoidosis. | EC Pulmonol Respir Med | 2025 | 41859724 | PubTator, text mining | PubMed |
| Combined therapy with the estrogen receptor ERα and IFNα-2b suppresses HBV replication by inducing GBP1 expression. | Front Immunol | 2025 | 41624844 | PubTator, text mining | PubMed |
| Identification of Differentially Expressed Genes and Molecular Pathways Involved in Primary Biliary Cholangitis Using RNA-Seq. | Genes (Basel) | 2025 | 41595430 | PubTator, text mining | PubMed |
| DENetwork unveils non-differentially expressed genes with functional relevance across conditions through information flow perturbation. | Nucleic Acids Res | 2025 | 41404797 | PubTator, text mining | PubMed |
| GBP1 as a machine learning-prioritized biomarker and therapeutic target for epstein-barr virus-induced clear cell renal cell carcinoma: multi-omics causal validation. | Int J Surg | 2025 | 41376480 | PubTator, text mining | PubMed |
| Recognition of Porphyromonas gingivalis lipopolysaccharide by human caspase-4 depends on lipopolysaccharide purity and guanylate-binding protein 1. | J Oral Microbiol | 2025 | 41341206 | PubTator, text mining | PubMed |
| A machine learning model and molecular clusters of epigenetic chromatin regulators in tuberculosis based on bioinformatics and clinical samples. | Sci Rep | 2025 | 41290882 | PubTator, text mining | PubMed |
| Porcine guanylate binding protein 1 inhibits the enzymatic activity of porcine caspase-3. | Int J Biol Macromol | 2025 | 41205950 | PubTator, text mining | PubMed |
| Breaking the heterogeneity barrier: a robust prognostic signature for survival stratification and immune profiling in triple-negative breast cancer. | Front Immunol | 2025 | 41098738 | PubTator, text mining | PubMed |
| Polysaccharides isolated from Ganoderma bambusicola: Structural characterization and in vitro bioactivities. | Int J Biol Macromol | 2025 | 41067340 | PubTator, text mining | PubMed |
| Spatially-restricted inflammation-induced senescent-like glia in multiple sclerosis and patient-derived organoids. | Nat Commun | 2025 | 41006208 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2633/papers?page=3